A random order for the first three cases to be tried in a multidistrict litigation blaming the antipsychotic drug Abilify for causing compulsive behaviors has been decided by U.S. District Judge M. Casey Rodgers. The cases are among about 750 pending in Florida federal court against Abilify makers Bristol-Myers Squibb and Otsuka Pharmaceutical. The cases are not intended to serve as true bellwethers because their selection was not based on an analysis of their characteristics or randomness. Instead, they were chosen for their convenience of being eligible for trial in the Northern District of Florida without a venue waiver. The ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.